These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 25787337
21. In vitro release testing methods for drug-releasing vaginal rings. Boyd P, Variano B, Spence P, McCoy CF, Murphy DJ, Dallal Bashi YH, Malcolm RK. J Control Release; 2019 Nov 10; 313():54-69. PubMed ID: 31626862 [Abstract] [Full Text] [Related]
22. Assessing the potential of the Woman's Condom for vaginal drug delivery. Kramzer LF, Cohen J, Schubert J, Dezzutti CS, Moncla BJ, Friend D, Rohan LC. Contraception; 2015 Sep 10; 92(3):254-60. PubMed ID: 25998936 [Abstract] [Full Text] [Related]
27. A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates. Su JT, Teller RS, Srinivasan P, Zhang J, Martin A, Sung S, Smith JM, Kiser PF. Pharm Res; 2017 Oct 10; 34(10):2163-2171. PubMed ID: 28770490 [Abstract] [Full Text] [Related]
28. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Woolfson AD, Malcolm RK, Morrow RJ, Toner CF, McCullagh SD. Int J Pharm; 2006 Nov 15; 325(1-2):82-9. PubMed ID: 16884869 [Abstract] [Full Text] [Related]
29. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1. Gupta KM, Pearce SM, Poursaid AE, Aliyar HA, Tresco PA, Mitchnik MA, Kiser PF. J Pharm Sci; 2008 Oct 15; 97(10):4228-39. PubMed ID: 18338805 [Abstract] [Full Text] [Related]
30. Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques. Dobard CW, Sharma S, Cong ME, West R, Makarova N, Holder A, Pau CP, Hanson DL, Novembre FJ, Garcia-Lerma JG, Heneine W. Retrovirology; 2015 Aug 08; 12():69. PubMed ID: 26253002 [Abstract] [Full Text] [Related]
31. Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study. Richardson-Harman N, Mauck C, McGowan I, Anton P. AIDS Res Hum Retroviruses; 2012 Nov 08; 28(11):1422-33. PubMed ID: 22900504 [Abstract] [Full Text] [Related]
35. Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection. Liu S, Lu H, Neurath AR, Jiang S. Antimicrob Agents Chemother; 2005 May 08; 49(5):1830-6. PubMed ID: 15855503 [Abstract] [Full Text] [Related]
36. Molecular dynamics simulations of UC781-cyclodextrins inclusion complexes in aqueous solution. Boonyarattanakalin K, Wolschann P, Toochinda P, Lawtrakul L. Eur J Pharm Sci; 2012 Nov 20; 47(4):752-8. PubMed ID: 22922099 [Abstract] [Full Text] [Related]
37. Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds. Goddeeris C, Coacci J, Van den Mooter G. Eur J Pharm Biopharm; 2007 May 20; 66(2):173-81. PubMed ID: 17158039 [Abstract] [Full Text] [Related]
38. Approaches to improve the stability of the antiviral agent UC781 in aqueous solutions. Damian F, Fabian J, Friend DR, Kiser PF. Int J Pharm; 2010 Aug 30; 396(1-2):1-10. PubMed ID: 20510342 [Abstract] [Full Text] [Related]